Setting Up for Success: A How-To Guide for Life After Fellowship

Many oncology fellows nearing the transition into the workforce face significant practice gaps in non-clinical skills essential for career advancement, including writing effective resumes tailored for academic and clinical positions, mastering interviewing techniques, and navigating salary negotiations. Additionally, there is a critical need for education on how to prepare for success as junior faculty members, including mentorship acquisition, time management, and balancing clinical, research, and teaching responsibilities.
Target Audience
This program is designed to meet the educational needs of physicians, nurses, PAs, pharmacists, and other health care professionals who manage patients with cancer.
Learning Objectives
Following this activity, participants should be able to:
- Identify strategies for achieving success as junior faculty members and describe common obstacles and pitfalls that may be faced in early career.
- Create tailored resumes and CVs that effectively highlight clinical, research, and teaching experience, ensuring competitiveness in both academic and clinical job markets.
- Demonstrate proficiency in interviewing techniques and salary negotiations that will enable fellows to confidently navigate job offers, articulate their value, and secure competitive compensation and contract terms.
Moderator
Carey B. Deacon
In addition, all content has been reviewed to ensure education promotes safe, effective patient care and does not promote the products or services of an ineligible company. Content, including any presentation of therapeutic options, is fair, balanced, evidence-based, scientifically accurate, and free of commercial bias and marketing.
Definitions
Ineligible Company: An ineligible company is any entity whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
Relevant Financial Relationships: Financial relationships of any dollar amount occurring within the past 24 months are defined as relevant if the educational content an individual can control is related to the business lines or products of an ineligible company. There is no minimum financial threshold. We ask for disclosure of ALL financial relationships with ineligible companies, regardless of the amount and regardless of the potential relevance of each relationship to the education.
Faculty Disclaimers
All faculty for this continuing education activity are competent in the subject matter and qualified by experience, training, and/or preparation for the tasks and methods of delivery. Faculty presentations may include discussion of off-label use. Faculty will disclose that the use in question is not currently approved by the FDA per the product labeling or marketing.
Faculty Disclosures
The faculty listed below have no relevant financial relationships with ineligible companies to disclose.
Juskaran S. Chadha, DO, MBA
Carey B. Deacon
The faculty listed below have the following relevant financial relationship(s) with ineligible companies to disclose. All of the relevant financial relationships listed for these individuals have been mitigated.
Timothy Kubal, MD, MBA
Alexion Pharmaceuticals, Inc.: Scientific Advisor
Novartis Pharmaceuticals Corporation: Consulting Fee
sanofi-aventis U.S.: Consulting Fee
Kevin P. Labadie, MD
Johnson & Johnson: Consulting Fee
NCCN Staff Disclosures
None of the planners for this educational activity have relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
![]() | In support of improving patient care, National Comprehensive Cancer Network (NCCN) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team. |
Physicians: NCCN designates this enduring material for a maximum of 1.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nurses: NCCN designates this educational activity for a maximum of 1.25 contact hours.
Pharmacists: NCCN designates this knowledge-based continuing education activity for 1.25 contact hours (0.125 CEUs) of continuing education credit. UAN: JA4008196-0000-26-046-H01-P
PAs: NCCN has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.25 AAPA Category 1 CME credits. Approval is valid until March 1, 2027. PAs should only claim credit commensurate with the extent of their participation.
Available Credit
- 1.25 AAPA Category 1 CME credit
- 1.25 ACPE contact hours
- 1.25 AMA PRA Category 1 Credit™
- 1.25 ANCC contact hours
- 1.25 Participation
Required Hardware/software
To complete this activity, users will need:
- A device with an Internet connection and sound playback capability (speakers or a headset)
- Adobe Reader or other PDF reader software for certificate viewing/printing

Facebook
X
LinkedIn
Forward